| Trial | Updated / Type |
Status | Phase | Were Results Reported |
Reported Actual Enrollment |
(MeSH) Terms |
Why Stopped
Limitations And Caveats |
Annotator decisions |
|---|---|---|---|---|---|---|---|---|
| NCT03585062 Details | 2021-01-08 Interventional | 2 | 40 | Paclitaxel Pancreatic Neop… Neoadjuvant Che… Pancreatic Canc… | The paclitaxel-albumin halt production. - | |||
| NCT01569035 Details | 2021-01-07 Interventional | 4 | 200 | Warfarin Oligohydramnios | - - | |||
| NCT03514277 Details | 2021-01-06 Interventional | 4 | 19 | Bupivacaine Intervertebral … Intervertebral … Low Back Pain Radiculopathy Spondylolisthes… Spondylolysis Deformity of Sp… Lumbar Disc Deg… Lumbar Disc Her… Lumbosacral Rad… Stenosis | PI decision to close study early Early termination leading to small numbers of subjects analyzed | |||
| NCT03342859 2017-000468-13 Details | 2021-01-06 Interventional | 1 | 10 | Ulipristal acet… Leiomyoma Myofibroma | Due to findings in the preclinical carcinogenicity studies for vilaprisan (BAY1002670) - | |||
| NCT03205046 Details | 2021-01-06 Interventional | 1/2 | 25 | Acalabrutinib DLBCL Richter Syndrom… | Sponsor's decision not to pursue further development of the combination in DLBCL Enrollment to this study was stopped early by the sponsor and an abbreviated CSR was generated. | |||
| NCT02619617 Details | 2021-01-05 Interventional | 2 | 28 | Pasireotide Cluster Headach… Headache Cluster Headach… | Novartis decision based on Cohort 1 results Terminated (Non-efficacy in first Phase 2a cohort.) | |||
| NCT02388165 2014-002644-40 Details | 2021-01-05 Interventional | 2 | 3450 | Vaccines Staphylococcal … | Study terminated by sponsor - | |||
| NCT02029274 2013-001799-39 Details | 2021-01-05 Interventional | 2 | 17 | Siponimod Dermatomyositis Active Dermatom… | The study was terminated prematurely after an interim analysis for futility. The study did not
provide any evidence for efficacy of BAF312 in dermatomyositis. - | |||
| NCT01801917 Details | 2021-01-05 Interventional | 2 | 14 | Siponimod Polymyositis | - - | |||
| NCT00760929 2008-001736-12 Details | 2021-01-05 Interventional | 2 | 171 | Antibodies, Mon… Erlotinib Hydro… Carcinoma, Non-… Lung Neoplasms Non-Squamous No… | The study was terminated due to the termination of the clinical development program. Development of the study drug R1570 was discontinued based on the available clinical data and the large number of molecules targeting the pathway. Not all efficacy parameters described in the protocol were assessed. | |||
| NCT03063359 Details | 2020-12-31 Interventional | 3 | 22 | Fentanyl Morphine Acute Pain Pain, Acute | The new pain protocols imposed by the HAS make it difficult to include new patients in the
study - | |||
| NCT01721317 2012-003105-10 Details | 2020-12-30 Interventional | 4 | 6 | Ezogabine Seizures | After reevaluation of the benefit: risk profile of ezogabine/retigabine, GSK does not believe
the early adjunctive treatment study population is appropriate. - | |||
| NCT03487198 Details | 2020-12-29 Interventional | 3 | 65 | Brexpiprazole Depression Depressive Diso… Depressive Diso… Major Depressiv… | In consideration of the progress now and the expected enrollment in the next few years,the NDA
will not be acquired before the patent went out. - | |||
| NCT02559817 Details | 2020-12-28 Interventional | 2 | 101 | Linaclotide Constipation Irritable Bowel… Syndrome Irritable Bowel… | - Due to slow participant enrollment, further screening was terminated. This decision was not due to any safety concern. | |||
| NCT01092975 Details | 2020-12-28 Interventional | 1 | 1 | Oxymetazoline Phenylephrine Mucositis Stomatitis | formulation/dose changes; planned changes to safety monitoring/reporting - | |||
| NCT02862535 Details | 2020-12-24 Interventional | 1 | [4 Refs] | 36 | Nivolumab Oxaliplatin Adenocarcinoma Gastric Adenoca… | Study was terminated due to sponsor's decision to not pursue further development of
andecaliximab in oncology - | ||
| NCT01156415 Details | 2020-12-24 Interventional | 3 | 837 | Agomelatine Depression Depressive Diso… Depressive Diso… Major Depressiv… | - - | |||
| NCT00738387 2008-002309-38 Details | 2020-12-24 Interventional | 3 | 900 | Docetaxel Vadimezan Carcinoma, Non-… Lung Neoplasms Non-Small Cell … | - - | |||
| NCT00662597 Details | 2020-12-24 Interventional | 3 | 1285 | Carboplatin Paclitaxel Vadimezan Carcinoma, Non-… Lung Neoplasms Non-Small Cell … | - - | |||
| NCT04681027 Details | 2020-12-23 Interventional | 3 | 15 | Oxymorphone Chronic Pain Pain, Postopera… Postsurgical Pa… | Study Suspended 06Feb2020 per FDA Request - |